Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 02 - 08 tags : Covid save search
QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year sales growth from non-COVID products
Published: 2022-02-08 (Crawled : 00:00) - biospace.com/
QGEN | $39.32 -0.88% 0.0% 740K
|
Health Technology
|
| O: -2.57%
H: 0.0%
C: 0.0%
QGEN | $39.32 -0.88% 0.0% 740K
|
Health Technology
|
| O: -2.57%
H: 0.0%
C: 0.0%
sales liver covid growth
Global Mechanical Pump Market Forecast to 2028 - COVID-19 Impact and Analysis
Published: 2022-02-08 (Crawled : 21:00) - prnewswire.com
XYL | $128.0 0.56% 0.0% 1.1M
|
Producer Manufacturing
|
| O: 1.99%
H: 2.25%
C: 2.12%
covid-19 covid
BD Collaborates with ReturnSafe to Help Employers Manage COVID-19 Testing
Published: 2022-02-08 (Crawled : 12:00) - prnewswire.com
BDX | $231.01 -1.58% 0.0% 1.1M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
covid-19 covid test collaboration
Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States
Published: 2022-02-08 (Crawled : 12:00) - biospace.com/
MRK | $125.06 -0.9% 0.0% 5.6M
|
Health Technology
|
| O: -2.14%
H: 0.3%
C: -0.25%
covid-19 state covid molnupiravir antiviral
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.